234 related articles for article (PubMed ID: 12115)
21. Long-term treatment of hypertension with labetalol.
Prichard BN; Boakes AJ; Hernández R
Br J Clin Pharmacol; 1979; 8(Suppl 2):171S-177S. PubMed ID: 526398
[TBL] [Abstract][Full Text] [Related]
22. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
Zech P; Pozet N; Sassard J; Vincent M
Nouv Presse Med; 1980 Mar; 9(15):1087-90. PubMed ID: 7008020
[TBL] [Abstract][Full Text] [Related]
23. [Labetalol: a new alpha/beta-adrenergic receptor blocking agent].
Gyimesi A; Hanyecz V; Pocsay G; Iványi J
Orv Hetil; 1981 Nov; 122(46):2831-4. PubMed ID: 7033885
[No Abstract] [Full Text] [Related]
24. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
[TBL] [Abstract][Full Text] [Related]
25. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
[TBL] [Abstract][Full Text] [Related]
26. A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group.
N Z Med J; 1981 Apr; 93(681):215-8. PubMed ID: 7017511
[TBL] [Abstract][Full Text] [Related]
27. Raynaud's phenomenon caused by beta-receptor blocking drugs. Improvement after treatment with a combined alpha- and beta-blocker.
Eliasson K; Danielson M; Hylander B; Lindblad LE
Acta Med Scand; 1984; 215(4):333-9. PubMed ID: 6145298
[TBL] [Abstract][Full Text] [Related]
28. Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise.
Koch G
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):729-32. PubMed ID: 10951
[TBL] [Abstract][Full Text] [Related]
29. A multicentre open trial of labetalol in New Zealand.
Br J Clin Pharmacol; 1979; 8(Suppl 2):179S-182S. PubMed ID: 393287
[TBL] [Abstract][Full Text] [Related]
30. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
[TBL] [Abstract][Full Text] [Related]
31. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
Mehta J; Cohn JN
Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
[TBL] [Abstract][Full Text] [Related]
32. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
Rasmussen S; Nielsen PE
Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
[TBL] [Abstract][Full Text] [Related]
33. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
Al-Damluji SF; Al-Khalidi A; Shaarbaf H; Tawfiq NH
Pharmatherapeutica; 1982; 3(2):133-9. PubMed ID: 7048338
[TBL] [Abstract][Full Text] [Related]
34. Labetalol: potent antihypertensive agent that blocks both alpha- and beta-adrenergic receptors.
Milne BJ; Logan AG
Can Med Assoc J; 1980 Nov; 123(10):1013-6. PubMed ID: 6256045
[TBL] [Abstract][Full Text] [Related]
35. Comparison of labetalol and propranolol in treatment of hypertension.
Harvald B
Postgrad Med J; 1980; 56 Suppl 2():65-8. PubMed ID: 7433346
[TBL] [Abstract][Full Text] [Related]
36. A comparative study of methyldopa and labetalol in the treatment of hypertension.
Sanders GL; Davies DM; Gales GM; Rao JG; Rawlins MD; Routledge PA
Br J Clin Pharmacol; 1979; 8(Suppl 2):149S-151S. PubMed ID: 393286
[TBL] [Abstract][Full Text] [Related]
37. [Therapy of hypertensive crises with a mono-substance with alpha- and beta-blocking properties (labetalol)].
Holzer H; Pogglitsch H; Katschnig H; Korthals C
Wien Med Wochenschr Suppl; 1981; 69():10-3. PubMed ID: 6952657
[TBL] [Abstract][Full Text] [Related]
38. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
Martinand A; Lardoux H; Corvol P; Milliez P
Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
[TBL] [Abstract][Full Text] [Related]
39. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
McNeil JJ; Louis WJ
Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
[TBL] [Abstract][Full Text] [Related]
40. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
Thompson FD; Joekes AM; Hussein MM
Br J Clin Pharmacol; 1979; 8(Suppl 2):129S-133S. PubMed ID: 526392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
